V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190003511 | 190003308 | null | null | null | null | 2016-03-28 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101522567 |
| 190003789 | 190003309 | null | null | null | null | 2018-04-29 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101294712 |
| 190003862 | 190003310 | 1.57 | 110 | Curative (C) | 2019-10-10 | 2019-10-17 | Capecitabine + Oxaliplatin 21day | 2 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100394493 |
| 190003948 | 190003311 | 1.6 | 61.8 | null | 2017-11-25 | 2019-04-25 | VDC | 01 | null | CISPLATIN + RT | 101226112 |
| 190004140 | 190003312 | null | null | null | null | 2018-11-13 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101394150 |
| 190004163 | 190003313 | 1.61 | 69.5 | Curative (C) | 2017-02-08 | 2017-02-09 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101625605 |
| 190004507 | 190003314 | null | null | null | null | 2016-11-09 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100253445 |
| 190004898 | 190003317 | null | null | null | null | 2017-03-06 | null | null | null | TRIAL | 101814779 |
| 190004933 | 190003318 | 0.78 | 78.9 | Curative (C) | 2018-11-13 | 2018-11-17 | VIDE | 02 | null | DOXORUBICIN + HD MTX | 100493281 |
| 190004955 | 190003319 | 1.73 | 61.8 | Palliative (P) | 2019-11-11 | 2019-11-17 | Cisplatin + Radiotherapy | N | N | EW EUROEWING 2012 ARM A VIDE | 101823843 |
| 190004965 | 190003320 | null | null | null | null | 2016-10-31 | Cisplatin + Etoposide po&iv 3 day | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100319012 |
| 190005045 | 190003321 | null | null | null | null | 2018-05-12 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100317823 |
| 190005062 | 190003322 | 1.77 | 52.4 | null | 2019-06-30 | 2019-07-18 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 101607809 |
| 190005128 | 190003323 | 1.57 | 68.3 | Curative (C) | 2019-03-23 | 2019-03-23 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | EURO-EWING | 100405325 |
| 190005135 | 190003324 | null | 67.9 | Adjuvant (A) | 2019-02-19 | 2019-02-19 | Carboplatin AUC 2 - 5 | 02 | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101292080 |
| 190005229 | 190003325 | 1.69 | 70 | null | 2021-04-04 | 2021-04-18 | VDC | null | null | TRIAL | 101462661 |
| 190005297 | 190003326 | null | 68 | Palliative (P) | 2017-02-05 | 2017-02-12 | PAM x 2 post-surgery (cycles 3&4) | N | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101013934 |
| 190005301 | 190003327 | 1.73 | 56.5 | Palliative (P) | 2018-10-21 | 2018-10-22 | ECX | 01 | N | DOXORUBICIN + HD MTX | 101602217 |
| 190005471 | 190003329 | null | null | null | null | 2019-10-27 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100817180 |
| 190005536 | 190003330 | 1.65 | 55 | Palliative (P) | 2018-07-25 | 2018-08-04 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 100026062 |
| 190005652 | 190003331 | null | null | null | null | 2019-11-10 | EOX | null | null | MAP | 100758168 |
| 190005821 | 190003332 | 1.65 | 76.3 | Palliative (P) | 2018-12-10 | 2018-12-15 | EW EuroEwing 2012 Arm A VAI | N | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100488274 |
| 190006061 | 190003334 | 1.72 | 91 | Curative (C) | 2017-02-18 | 2017-02-18 | Cisplatin + Doxorubicin | null | N | CISPLATIN + DOXORUBICIN | 100795583 |
| 190006089 | 190003335 | 1.83 | 67.7 | Curative (C) | 2017-07-26 | 2017-07-27 | EP 1 2 or 3 day | 01 | N | DOXORUBICIN + METHOTREXATE | 100145043 |
| 190006316 | 190003336 | 1.7 | 57.1 | Curative (C) | 2019-09-02 | 2019-09-05 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101717386 |
| 190006342 | 190003337 | null | null | null | null | 2018-12-16 | GemCarbo Days 1+8 | null | null | EURO-EWING | 100643983 |
| 190006487 | 190003339 | null | null | null | null | 2017-10-21 | MAP | null | null | DOXORUBICIN + METHOTREXATE | 101098407 |
| 190006530 | 190003340 | null | null | null | null | 2017-11-09 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100393769 |
| 190006651 | 190003341 | 1.65 | 84 | Curative (C) | 2016-09-18 | 2016-09-24 | OST Euramos 1 Closed Trial - AP | null | N | CARBOPLATIN | 101063229 |
| 190006668 | 190003342 | 1.77 | 66 | Palliative (P) | 2019-07-07 | 2019-07-08 | Cisplatin + Radiotherapy | N | N | DOXORUBICIN + METHOTREXATE | 100569073 |
| 190006786 | 190003344 | 1.7 | 65 | null | 2017-06-08 | 2017-06-12 | EVEROLIMUS | 2 | null | TRIAL | 100307503 |
| 190006894 | 190003345 | 1.63 | 77.4 | Curative (C) | null | 2018-04-06 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101097341 |
| 190007060 | 190003346 | 1.47 | 103 | Adjuvant (A) | 2015-09-05 | 2015-09-05 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100854380 |
| 190007112 | 190003348 | null | null | null | null | 2016-12-16 | CISPLATIN + ETOPOSIDE | null | null | EW EUROEWING 2012 ARM A VIDE | 101211580 |
| 190007202 | 190003349 | null | null | null | null | 2017-10-31 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100472873 |
| 190007243 | 190003350 | null | null | null | null | 2019-06-21 | CISPLATIN + DOXORUBICIN + METHOTREXATE | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100539888 |
| 190007264 | 190003351 | null | null | null | null | 2017-04-16 | Cisplatin + Radiotherapy | null | null | CARBOPLATIN | 101834705 |
| 190007294 | 190003352 | 1.68 | 87.4 | Adjuvant (A) | 2018-11-21 | 2018-12-28 | EOX | 02 | N | MAP | 101777522 |
| 190007312 | 190003353 | 1.43 | 6.5 | Curative (C) | 2016-08-27 | 2016-09-11 | Cisplatin + Doxorubicin | Y | N | CISPLATIN + DOXORUBICIN | 100869538 |
| 190007635 | 190003357 | 1.54 | 65 | Palliative (P) | 2016-09-16 | 2016-09-16 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100693012 |
| 190007879 | 190003358 | 1.6 | 85.4 | Curative (C) | 2019-04-02 | 2019-04-16 | Cisplatin + Doxorubicin | 2 | Y | CISPLATIN + DOXORUBICIN | 101522657 |
| 190008157 | 190003359 | null | null | null | null | 2016-06-03 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100500752 |
| 190008183 | 190003360 | null | null | null | null | 2019-02-26 | Capecitabine + Oxaliplatin 21day | null | null | DOXORUBICIN + METHOTREXATE | 101496769 |
| 190008664 | 190003361 | 0 | 53.4 | Curative (C) | 2018-11-20 | 2018-11-23 | VIDE | 02 | Y | MIFAMURTIDE | 101867880 |
| 190008940 | 190003362 | 1.7 | 65 | Palliative (P) | 2017-03-01 | 2017-03-18 | CISPLATIN + FLUOROURACIL | N | N | TRIAL UNSPECIFIED | 101338788 |
| 190009318 | 190003364 | 1.59 | 75.5 | Adjuvant (A) | 2017-08-03 | 2017-08-08 | LANREOTIDE | 01 | N | OST AI | 101263266 |
| 190009411 | 190003365 | null | null | null | null | 2019-08-21 | ECX | null | null | MAP | 101440369 |
| 190010127 | 190003367 | 1.79 | 75.6 | Palliative (P) | 2018-08-15 | 2018-09-25 | EW EuroEwing 99 : VIDE | N | N | CARBOPLATIN | 100767437 |
| 190010000 | 190003374 | 1.95 | 58 | 03 | 2016-11-24 | 2016-12-13 | Cisplatin + Radiotherapy | 02 | N | EURAMOS TRIAL | 101698267 |
| 190000058 | 190003379 | null | null | Curative (C) | null | 2017-10-20 | null | null | null | MIFAMURTIDE | 101694014 |